Enhancement of antibody response by high mobility group box protein-1-based DNA immunization

Journal of Immunological Methods

Volumn 361, Issue 1-2, 2010, Pages 21-30

  Kimura, Ryuichiro ^a   Shiibashi, Ryota ^a   Suzuki, Masanori ^b   Hayashizaki, Yoshihide ^c   Chiba, Joe ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

Antibody response; DNA immunization; High mobility group box protein 1 (HMGB1); HMGB1 antigen conjugates; Release type HMGB1 mutants; Th1 antibody

Indexed keywords

GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; OVALBUMIN; PLASMID VECTOR; ANTIBODY; DNA VACCINE; HIGH MOBILITY GROUP B PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CYTOKINE RELEASE; DENDRITIC CELL; DNA IMMUNIZATION; ELECTROPORATION; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; C57BL MOUSE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; GENETICS; GERMFREE ANIMAL; IMMUNIZATION; IMMUNOLOGY; PLASMID; PROCEDURES; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; HMGB PROTEINS; IMMUNITY, HUMORAL; IMMUNIZATION; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; OVALBUMIN; PLASMIDS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, DNA;

ANIMALIA;

EID: 77956878233     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.05.001     Document Type: Article

References (23)

1. Ainai A., Kawase T., Ida A., Maeda Y., Ohba H., Ikeda Y., Sato H., Takahashi M., Chiba J. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells. Hum. Antibodies 2006, 15:139-154.
2. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
3. Berzofsky J.A., Ahlers J.D., Belyakov I.M. Strategies for designing and optimizing new generation vaccines. Nat. Rev. Immunol. 2001, 1:209-219.
4. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003, 22:5551-5560.
5. Donnelly J.J., Wahren B., Liu M.A. DNA vaccines: progress and challenges. J. Immunol. 2005, 175:633-639.
6. Dumitriu I.E., Baruah P., Manfredi A.A., Bianchi M.E., Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol. 2005, 26:381-387.
7. Faham A., Bennett D., Altin J.G. Liposomal Ag engrafted with peptides of sequence derived from HMGB1 induce potent Ag-specific and anti-tumour immunity. Vaccine 2009, 27:5846-5854.
8. Fujimoto A., Takatsuka S., Ishida I., Chiba J. Production of human antibodies to native cytokine receptors using the genetic immunization of KM mice. Hum. Antibodies 2009, 18:75-80.
9. Hock R., Furusawa T., Ueda T., Bustin M. HMG chromosomal proteins in development and disease. Trends Cell Biol. 2007, 17:72-79.
10. Ito I., Fukazawa J., Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 2007, 282:16336-16344.
11. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 1995, 23:3816-3821.
12. Liu M.A. DNA vaccines: a review. J. Intern. Med. 2003, 253:402-410.
13. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 2005, 5:331-342.
14. Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., Tracey K.J., Chiorazzi N. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 2004, 173:307-313.
15. Muthumani G., Laddy D.J., Sundaram S.G., Fagone P., Shedlock D.J., Kannan S., Wu L., Chung C.W., Lankaraman K.M., Burns J., Muthumani K., Weiner D.B. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells. Immunology 2009, 128:e612-e620.
16. Rovere-Querini P., Capobianco A., Scaffidi P., Valentinis B., Catalanotti F., Giazzon M., Dumitriu I.E., Müller S., Iannacone M., Traversari C., Bianchi M.E., Manfredi A.A. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 2004, 5:825-830.
17. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000, 191:423-434.
18. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
19. Taylor J., Babbs C.F., Alzghoul M.B., Olsen A., Latour M., Pond A.L., Hannon K. Optimization of ectopic gene expression in skeletal muscle through DNA transfer by electroporation. BMC Biotechnol. 2004, 4:11.
20. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L.L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M.K., Fitzgerald K.A., Latz E., Kiener P.A., Coyle A.J. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007, 8:487-496.
21. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
22. Weiner G.J. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J. Leukoc. Biol. 2000, 68:455-463.
23. Youn J.H., Shin J.S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 2006, 177:7889-7897.